Episode Details

Merck’s groundbreaking new cholesterol drug, Lipfendra, just got FDA approval and is set to hit shelves in weeks—offering a powerful new weapon in the fight against heart disease. This first-in-class oral medication slashes “bad” LDL cholesterol by nearly 60%, targeting a key protein linked to cardiovascular risk. With 1 in 4 Americans battling high cholesterol, Lipfendra could transform treatment options for those at risk, especially those whose cholesterol stems from genetics or other health factors. Don’t miss this major development for heart health.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/491dc62a7d179958